A systematic review found that while genomic classifier (GC) tests may influence risk classifications or treatment decisions for patients with localized prostate cancer (PCa), there is a need for ...

In this systematic review, ten studies reported risk reclassification of prostate cancer with genome classifier testing, with ...

PSMA PET scans enable precise detection of prostate cancer even in its earliest stages, improving diagnostic accuracy and ...

A groundbreaking study has shown that a drug currently being tested for ovarian and bile duct cancer, called NXP800, could ...

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...

Rates of breast and thyroid cancer for women under 50 rose from 2002 to 2021, while men in the same age group had declining ...

Despite a big increase in “watchful waiting” in the past 15 years, there’s a new study from the U.S. Department of Veterans Affairs health system shows that overtreatment of prostate cancer persists.

Prostate cancer treatment guidelines recommend against aggressive therapy for those with a life expectancy of less than 10 years.

New consensus recommendations address implementation of novel treatments and imaging techniques for advanced and ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

After skin cancer, prostate cancer is the most common cancer in men in the US. For the men who have beat prostate cancer once ...